An active immunotherapy against neurodegenerative disorders

Parkinson’s disease (PD) and multiple system atrophy (MSA) are two neurodegenerative disorders and, so far, only treatment of the symptoms is available. European scientists have developed vaccines to reduce severity of the diseases and improve patient function.

PD and MSA, also known as alpha-synucleinopathies, are two debilitating neurodegenerative disorders associated with a progressive decline in motor functions, autonomic disorders, as well as behavioural changes. MSA progresses very rapidly with patients dying within 10 years of disease onset.

Further details: An active immunotherapy against neurodegenerative disorders